Welcome to The Breast Cancer Network News

The BCN News provides its thousands of readers with breaking news on breast cancer treatment and research daily. Along with thousands of breast cancer patients and survivors, The BCN News is read in nearly every major cancer and health organization, all the major breast cancer organizations, and major research laboratories and universities around the world.

For a free trial subscription to The BCN News, sign up here, or use the following Constant Contact subscribe option:

Join Our Mailing List
Email:


BCN News Articles for: January 16, 2018

  • Gene Test to Predict Breast Cancer Recurrence Less Cost Effective in Real World Practice
  • Cost Effectiveness of Gene Expression Profile Testing in Community Practice
  • Long-term survival outcomes of triple-receptor negative breast cancer survivors who are disease free at 5 years and relationship with low hormone receptor positivity
  • Acupuncture and Reflexology for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer
  • Consumption of Fresh Yellow Onion Ameliorates Hyperglycemia and Insulin Resistance in Breast Cancer Patients During Doxorubicin-Based Chemotherapy: A Randomized Controlled Clinical Trial
  • Evaluation of Active Hexose Correlated Compound (AHCC) in Combination With Anticancer Hormones in Orthotopic Breast Cancer Models
  • Comparing Outcomes of Genetic Counseling Options in Breast and Ovarian Cancer: An Integrative Review
  • Validation of the Lymphedema Life Impact Scale Version 2: A Condition-Specific Measurement Tool for Persons With Lymphedema
  • Routine assessment of unmet needs in individuals with advanced cancer and their caregivers: A qualitative study of the palliative care needs assessment tool (PC-NAT)
  • Variation in 'fast-track' referrals for suspected cancer by patient characteristic and cancer diagnosis: evidence from 670,000 patients with cancers of 35 different sites
  • Salk scientists curb growth of cancer cells by blocking access to key nutrients
  • Pharmacological activation of REV-ERBs is lethal in cancer and oncogene-induced senescence


The BCN News: The Cancer News You Need To Know

Not a subscriber yet? Sign up now for a free 2-week trial subscription.


© 1996 - 2018 WebFeats, Inc.
For Carol